Short-term memory loss is scary because one would expect things that they just saw to be front of their mind. If you feel ...
In this video from the American Academy of Ophthalmology meeting, Philip J. Ferrone, MD, discusses the TEASE-2 trial results in treating Stargardt disease with gildeuretinol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback